99 related articles for article (PubMed ID: 2620541)
21. Allograft heart accelerated atherosclerosis: evidence for cell-mediated immunity in pathogenesis.
Gravanis MB
Mod Pathol; 1989 Sep; 2(5):495-505. PubMed ID: 2813347
[TBL] [Abstract][Full Text] [Related]
22. Hypercholesterolemia does not exacerbate arterial intimal thickening in chronically rejecting rat cardiac allografts.
Adams DH; Karnovsky MJ
Transplant Proc; 1989 Feb; 21(1 Pt 1):437-9. PubMed ID: 2650168
[No Abstract] [Full Text] [Related]
23. Accelerated coronary atherosclerosis in the allograft heart.
Gravanis MB
Postgrad Med J; 1994; 70 Suppl 1():S93-8. PubMed ID: 7971656
[No Abstract] [Full Text] [Related]
24. Arteriosclerosis in transplanted hearts: too much and too soon.
Libby P; Pober JS; Swanson SJ; Mudge GH; Schoen FJ
Can J Cardiol; 1991 Apr; 7(3):XI-XII. PubMed ID: 2044011
[No Abstract] [Full Text] [Related]
25. Acute cytomegalovirus infection induces a subendothelial inflammation (endothelialitis) in the allograft vascular wall. A possible linkage with enhanced allograft arteriosclerosis.
Koskinen P; Lemström K; Bruggeman C; Lautenschlager I; Häyry P
Am J Pathol; 1994 Jan; 144(1):41-50. PubMed ID: 8291611
[TBL] [Abstract][Full Text] [Related]
26. CMV and transplant-related coronary atherosclerosis: an immunohistochemical, in situ hybridization, and polymerase chain reaction in situ study.
Sambiase NV; Higuchi ML; Nuovo G; Gutierrez PS; Fiorelli AI; Uip DE; Ramires JA
Mod Pathol; 2000 Feb; 13(2):173-9. PubMed ID: 10697275
[TBL] [Abstract][Full Text] [Related]
27. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
[TBL] [Abstract][Full Text] [Related]
28. Graft coronary arteriosclerosis in rat heart transplant model with FK 506 short-term administration.
Izutani H; Miyagawa S; Matsumiya G; Nakata S; Shimazaki Y; Matsuda H; Shirakura R
Transplant Proc; 1995 Feb; 27(1):579-81. PubMed ID: 7533425
[No Abstract] [Full Text] [Related]
29. Role of hypercholesterolemia in accelerated transplant coronary vasculopathy: results of surgical therapy with partial ileal bypass in rabbits undergoing heterotopic heart transplantation.
Esper E; Glagov S; Karp RB; Simonsen KK; Filer SR; Scanu AM; Sand ME
J Heart Lung Transplant; 1997 Apr; 16(4):420-35. PubMed ID: 9154953
[TBL] [Abstract][Full Text] [Related]
30. Granzyme B in atherosclerosis and transplant vascular disease: association with cell death and atherosclerotic disease severity.
Choy JC; McDonald PC; Suarez AC; Hung VH; Wilson JE; McManus BM; Granville DJ
Mod Pathol; 2003 May; 16(5):460-70. PubMed ID: 12748253
[TBL] [Abstract][Full Text] [Related]
31. No coronary atherosclerotic changes were found after heart transplantation in tolerance-induced rats.
Ito H; Hamano K; Suzuki K; Shirasawa B; Gohra H; Katoh T; Fujimura Y; Tsuboi H; Esato K
Transplant Proc; 1996 Jun; 28(3):1823. PubMed ID: 8658900
[No Abstract] [Full Text] [Related]
32. The pathogenesis of coronary arteriosclerosis ("chronic rejection") in transplanted hearts.
Libby P; Tanaka H
Clin Transplant; 1994 Jun; 8(3 Pt 2):313-8. PubMed ID: 7520306
[TBL] [Abstract][Full Text] [Related]
33. The effect of platelet-derived growth factor ligands in rat cardiac allograft vasculopathy and fibrosis.
Tuuminen R; Nykänen A; Keränen MA; Krebs R; Alitalo K; Koskinen PK; Lemström KB
Transplant Proc; 2006 Dec; 38(10):3271-3. PubMed ID: 17175246
[TBL] [Abstract][Full Text] [Related]
34. The pathogenesis of graft vascular disease: implications of vascular remodeling.
Gibbons GH
J Heart Lung Transplant; 1995; 14(6 Pt 2):S149-58. PubMed ID: 8719477
[No Abstract] [Full Text] [Related]
35. Amlodipine reduces graft coronary artery disease in rat heterotopic cardiac allografts.
Atkinson JB; Wudel JH; Hoff SJ; Stewart JR; Frist WH
J Heart Lung Transplant; 1993; 12(6 Pt 1):1036-43. PubMed ID: 8312305
[TBL] [Abstract][Full Text] [Related]
36. [Fine-structural analysis of hyper-acute rejection in cardiac xenotransplantation].
Miyazaki K
Hokkaido Igaku Zasshi; 2000 Sep; 75(5):347-56. PubMed ID: 11070795
[TBL] [Abstract][Full Text] [Related]
37. Experimental cardiac allograft vasculopathy in mice.
Ardehali A; Billingsley A; Laks H; Drinkwater DC; Sorensen TJ; Drake TA
J Heart Lung Transplant; 1993; 12(5):730-5. PubMed ID: 8241210
[TBL] [Abstract][Full Text] [Related]
38. Protective effect of beraprost sodium, a stable prostacyclin analogue, on cardiac allograft vasculopathy in rats.
Kurisu Y; Orihashi K; Sueda T; Kajihara H; Matsuura Y
Hiroshima J Med Sci; 1997 Mar; 46(1):11-9. PubMed ID: 9114563
[TBL] [Abstract][Full Text] [Related]
39. Diltiazem preserves direct vasodilator response but fails to suppress intimal proliferation in rat allograft coronary artery disease.
Takami H; Backer CL; Crawford SE; Pahl E; Mavroudis C
J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):67-77. PubMed ID: 8820085
[TBL] [Abstract][Full Text] [Related]
40. Time course of coronary endothelial dysfunction in acute untreated rejection after heterotopic heart transplantation.
Perrault LP; Bidouard JP; Janiak P; Villeneuve N; Bruneval P; Vilaine JP; Vanhoutte PM
J Heart Lung Transplant; 1997 Jun; 16(6):643-57. PubMed ID: 9229295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
